Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

CNC

Centene Corp

Feb 06 • 04:00PM ET

38.46

-1.46 -3.66 %

Healthcare • Healthcare Plans • USA • NYSE

Feb 06, 5:51 PMCentene posts a narrower‑than‑expected Q4 adjusted loss on better‑than‑forecast revenue and says it completed the Magellan Health asset divestiture in December with a $389M after‑tax impairment; it raised 2025 adjusted EPS guidance to $2.08 and set 2025 revenue at $186.5–$190.5B. On its Q4 call, Centene targeted 2026 adjusted EPS above $3 on $170–$174B revenue (HBR ~91%, assuming a 4.5% Medicaid rate increase) and said 2026 earnings will be highly seasonal with most EPS in Q1 and an expected Q4 loss amid Medicaid and Marketplace margin recovery.

Peers: UNH CI HUM MOH CVS VRTX

| Held by: VTI VOO IVV VB SPY VO RSP VBR XLV VTV

Index	S&P 500	P/E	-	EPS (ttm)	-13.62	Insider Own	2.73%	Shs Outstand	491.76M	Perf Week	-11.22%
Market Cap	18.90B	Forward P/E	9.05	EPS next Y	4.25	Insider Trans	-0.35%	Shs Float	478.11M	Perf Month	-15.97%
Enterprise Value	-	PEG	0.19	EPS next Q	2.23	Inst Own	95.59%	Short Float	2.56%	Perf Quarter	4.40%
Income	-6.67B	P/S	0.10	EPS this Y	44.76%	Inst Trans	-3.01%	Short Ratio	1.74	Perf Half Y	52.26%
Sales	194.78B	P/B	0.95	EPS next Y	41.14%	ROA	-8.33%	Short Interest	12.23M	Perf YTD	-6.54%
Book/sh	40.57	P/C	-	EPS next 5Y	46.48%	ROE	-28.79%	52W High	66.03 -41.75%	Perf Year	-36.67%
Cash/sh	-	P/FCF	4.37	EPS past 3/5Y	- -	ROIC	-17.89%	52W Low	25.08 53.38%	Perf 3Y	-48.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.45% 11.88%	Gross Margin	-	Volatility	4.83% 3.95%	Perf 5Y	-35.47%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-317.13%	Oper. Margin	-0.15%	ATR (14)	1.77	Perf 10Y	23.94%
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	19.44%	Profit Margin	-3.43%	RSI (14)	32.43	Recom	2.58
Dividend Gr. 3/5Y	- -	Current Ratio	1.10	EPS Q/Q	-497.29%	SMA20	-12.77%	Beta	0.51	Target Price	44.27
Payout	0.00%	Debt/Eq	0.87	Sales Q/Q	21.86%	SMA50	-8.14%	Rel Volume	2.36	Prev Close	39.92
Employees	60500	LT Debt/Eq	0.87	Earnings	Feb 06 BMO	SMA200	-5.57%	Avg Volume	7.03M	Price	38.46
IPO	Dec 13, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.55% 2.77%	Trades		Volume	16,602,653	Change	-3.66%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Barclays	Equal Weight → Overweight	$54
Oct-14-25	Initiated	Goldman	Sell	$33
Jul-28-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$38
Jul-23-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$30
Jul-21-25	Downgrade	TD Cowen	Buy → Hold	$33
Jul-16-25	Downgrade	BofA Securities	Neutral → Underperform	$30
Jul-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$33
Jul-02-25	Downgrade	UBS	Buy → Neutral	$45
Jul-02-25	Downgrade	JP Morgan	Overweight → Neutral	$48
Jun-09-25	Resumed	Morgan Stanley	Overweight	$70
Jun-02-25	Downgrade	Barclays	Overweight → Equal Weight	$65
Apr-08-25	Upgrade	Jefferies	Underperform → Hold	$64
Feb-06-25	Downgrade	Argus	Buy → Hold
Dec-17-24	Resumed	JP Morgan	Overweight	$80 → $75
Dec-13-24	Upgrade	UBS	Neutral → Buy	$79 → $80
Dec-10-24	Downgrade	Jefferies	Hold → Underperform	$68 → $52
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$83 → $69
May-30-24	Initiated	Robert W. Baird	Neutral	$83
Mar-21-24	Downgrade	Stephens	Overweight → Equal-Weight	$92 → $85
Mar-06-24	Initiated	Barclays	Overweight	$101

Show Previous Ratings

Feb-06-26 05:33PM	Centene Q4 Earnings Call Highlights (MarketBeat)
04:28PM	Molina Healthcare Stock Notches Lowest Close in Six Years. Why Its Earnings Outlook Is So Bleak. (Barrons.com)
04:01PM	Centene Corp (CNC) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting Sights ... (GuruFocus.com)
01:49PM	Centene Takes A Hit As Medicaid Membership Shrinks (Benzinga)
01:23PM	Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength (Zacks)
12:35PM	Loading…
12:35PM	Molina, Centene Fall on Concerns About Medicaid Business (The Wall Street Journal)
11:58AM	Analyst Report: Centene Corporation (Morningstar Research)
11:17AM	Centene Releases 2026 Profit Outlook Above Estimates as Shares Fall 6% (GuruFocus.com)
11:00AM	Health Net and Pro Football Hall of Fame Honor Sacramento Community and Inspire Local Youth During Super Bowl Week (PR Newswire)
10:45AM	S&P 500 Health Insurer Dives As ACA Enrollment Implodes (Investor's Business Daily)
09:30AM	Centene (CNC) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:25AM	Centene (CNC) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
07:13AM	Molina Healthcare Stock Falls 27%. Why Its Earnings Outlook Is So Bleak. (Barrons.com)
06:56AM	Centene (NYSE:CNC) Surprises With Q4 CY2025 Sales (StockStory)
06:56AM	Centene Swings to Loss Despite Higher Revenue (The Wall Street Journal)
06:34AM	Loading…
06:34AM	Centene: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE (PR Newswire)
Feb-05-26 10:59AM	UnitedHealth's Q4 Beat Can't Stop the Slide: Should You Let Go Now? (Zacks)
10:32AM	Analyst Report: The Cigna Group (Morningstar Research)
07:10AM	Cigna (CI) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-04-26 10:02PM	Centene (CNC) Q4 Earnings: What To Expect (StockStory)
09:41PM	Centene Corporation (CNC): A Bull Case Theory (Insider Monkey)
06:46AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The StartPBM 'Spread Pricing' Comes Under Fire (Benzinga)
Feb-03-26 12:36PM	Can Centene's Q4 Earnings Escape Membership & Cost Headwinds? (Zacks)
03:08AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start-PBM 'Spread Pricing' Comes Under Fire (Benzinga)
Feb-02-26 08:54AM	Are Wall Street Analysts Bullish on Centene Stock? (Barchart)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 07:38AM	Mizuho Updates Centene (CNC) Valuation as Physician Survey Suggests Cooling Healthcare Utilization (Insider Monkey)
Jan-29-26 08:30AM	Meridian Health Plan of Illinois and Centene Foundation Award $2.2 Million Grant to Safer Foundation for Purchase and Renovation of Affordable Housing Building in Chicago (PR Newswire)
02:19AM	Loading…
02:19AM	Trump's Flat Rate Medicare Advantage Proposal Is 'Shock To The System,' Risking 20% Earnings Hit, Delaying Healthcare Turnaround (Benzinga)
Jan-28-26 12:03PM	WellCare of Kentucky and Centene Foundation Give $145,000 to Food Pantries to Help Tackle Food Insecurity in Kentucky (PR Newswire)
10:31AM	Centene (CNC) Loses 10% on Flat Medicare Funding (Insider Monkey)
08:01AM	Nine S&P 500 Stocks' Earnings Are About To Crash In A Big Way (Investor's Business Daily)
Jan-27-26 04:44PM	Humana, UnitedHealth, CVS Stocks Tumble After Medicare Rates Blow (Barrons.com) -10.26%
04:44PM	Humana, UnitedHealth, and CVS Stocks Plunge After Setback on Medicare Rates (Barrons.com)
04:34PM	S&P 500 Posts a Record High on Tech Strength and Solid Corporate Earnings (Barchart)
04:13PM	Medicare Shock Wipes Out Nearly $100 Billion in Market Value (The Wall Street Journal)
12:55PM	S&P 500 Hits New Records, GM Stock Jumps 8% On Earnings: What's Moving Markets Tuesday? (Benzinga)
12:20PM	Why Centene (CNC) Shares Are Trading Lower Today (StockStory)
11:15AM	Broader Market Rallies on Tech Strength and Solid Earnings (Barchart)
10:39AM	Centene (CNC) Stock Slides After Medicare Advantage Update (Benzinga)
10:35AM	Medicare Shock Wipes Out $92 Billion in Market Value (The Wall Street Journal)
10:07AM	Stocks Edge Higher as Chip Makers Rally (Barchart)
09:55AM	Health insurers slide after 2027 Medicare Advantage payments proposal underwhelms (Investing.com)
08:52AM	UnitedHealth Tanks on Medicare Rates Shock. Time to Sell the Insurance Giant? (24/7 Wall St.)
07:17AM	Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling (Benzinga)
07:16AM	UnitedHealth, Humana, CVS Dive On Flat 2027 Medicare Advantage Rates; UNH Earnings Mixed (Investor's Business Daily)
07:15AM	Humana, UnitedHealth and Other Health-Insurer Stocks Slide on Medicare Proposal (The Wall Street Journal)
03:18AM	Health-Insurer Stocks Slide After Medicare Rate Proposal (The Wall Street Journal)
Jan-26-26 11:35PM	1 Unprofitable Stock to Keep an Eye On and 2 We Question (StockStory)
10:16PM	Analyst Report: The Cigna Group (Morningstar Research)
10:16PM	Analyst Report: Centene Corporation (Morningstar Research)
Jan-22-26 08:00AM	Superior HealthPlan Names CommUnityCare and Dell Children's as First Austin Providers to Earn Foster Care Distinction (PR Newswire)
Jan-21-26 01:29PM	Centene Expands Palliative Care Access in Ohio Through Tuesday Health (Zacks)
Jan-20-26 09:48AM	Tuesday Health and Buckeye Health Plan Partner to Bring Palliative Care for Ohioans with Serious Illness (PR Newswire)
Jan-19-26 09:33AM	The Zacks Analyst Blog Highlights UnitedHealth Group, Centene, Humana and Elevance Health (Zacks)
07:38AM	Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan (Zacks)
Jan-16-26 10:47AM	President Trump's Great Healthcare Plan: How Insurers Are Impacted? (Zacks)
Jan-15-26 03:10PM	Trump unveils his 'Great Healthcare Plan.' Analysts don't expect much of an impact. (MarketWatch)
12:04PM	Trumps Great Healthcare Plan Aims to Lower Drug Prices and Insurance Premiums (Bloomberg)
08:00AM	Congress Remains Stuck on Obamacare Credits as Enrollment Closes (Bloomberg)
Jan-13-26 04:30PM	CENTENE CORPORATION TO HOST 2025 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL (PR Newswire)
05:30AM	Why Healthcare's Stock-Market Winners and Losers Could Soon Trade Places (The Wall Street Journal)
Jan-08-26 12:21PM	CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois (Zacks)
Jan-07-26 08:00AM	Cityblock Health and Meridian Health Plan of Illinois Announce Partnership to Serve 10,000 Medicaid Members (PR Newswire)
Jan-06-26 11:04AM	Centene Jumps 16.3% in 3 Months: A Comeback or Calm Before the Storm? (Zacks)
07:04AM	Centene Earnings Preview: What to Expect (Barchart)
Jan-05-26 12:16PM	Centene (CNC) Stock Trades Up, Here Is Why (StockStory) +6.94%
11:08AM	Berkshire Hathaway dethrones Allianz as worlds largest insurer (Investing.com)
07:15AM	Centene Corporation (CNC) Fell in Q3 As It Retracted Its 2025 Guidance (Insider Monkey)
Jan-01-26 11:05PM	Centene (CNC): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-30-25 10:16AM	Why Humana Deserves Patience Now: Too Early to Buy, Too Risky to Sell (Zacks)
Dec-29-25 08:12PM	Health Net Providing Special Assistance to Members Affected by the Atmospheric Rivers Due to the "2025 Late December Storms" in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and Shasta Counties (PR Newswire)
Dec-23-25 09:08AM	eHealth's Guidance Update: Here's What a Strong AEP Signals (Zacks)
Dec-22-25 11:33PM	3 Mid-Cap Stocks with Warning Signs (StockStory)
Dec-19-25 08:45AM	Democrats Pounce as Congress Allows Obamacare Premiums to Spike (Bloomberg)
Dec-17-25 03:01PM	Ambetter Health & Tampa Bay Buccaneers Launch "Stay Healthy, Stay in the Game" PSA Urging Floridians to Prioritize Preventive Care Before Year-End (PR Newswire)
01:00PM	Sunshine Health Partners with Local Women Athletes to Champion Health Awareness (PR Newswire)
10:56AM	Oscar Health Rises As GOP Moderates Rebel Over ACA (Investor's Business Daily)
09:10AM	Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026 (Zacks)
07:11AM	S&P 500 Health Care Stocks Sink Ahead Of ACA Showdown (Investor's Business Daily)
07:11AM	ACA Subsidy Showdown Batters S&P 500 Healthcare Stocks (Investor's Business Daily)
Dec-16-25 04:01PM	Why Centene (CNC) Shares Are Sliding Today (StockStory)
02:10PM	S&P 500 Health Care Stocks Sink As Time Runs Out On ACA Subsidies (Investor's Business Daily)
03:56AM	Zacks Industry Outlook UnitedHealth, Humana and Centene (Zacks)
Dec-15-25 12:35PM	3 HMO Stocks in Focus Despite Rising Medical Costs, Regulatory Pressures (Zacks)
Dec-12-25 03:22PM	S&P 500 Stocks: UnitedHealth, Centene Rise Amid Push For House ACA Vote (Investor's Business Daily)
Dec-11-25 11:35PM	2 Healthcare Stocks with Exciting Potential and 1 We Ignore (StockStory)
03:00PM	Health Net Providing Special Assistance to Members and Providers Affected by The Pack Fire in California (PR Newswire)
01:08PM	Senate Rejects Obamacare Credit Renewal, Teeing Up Premium Spike (Bloomberg)
11:41AM	Centene (CNC) Stock Trades Up, Here Is Why (StockStory)
Dec-09-25 11:33PM	1 Stock Under $50 Worth Your Attention and 2 We Brush Off (StockStory)
Dec-04-25 07:37AM	Is Centene Stock Underperforming the S&P 500? (Barchart)
Dec-03-25 07:51AM	Here's Why Centene Corporation (CNC) Reduced Its Earnings Outlook (Insider Monkey)
Dec-02-25 09:39AM	Meridian Health Plan of Illinois Commits $1.15 Million to Expand St. Louis Area Foodbank Mobile Pantry Program (PR Newswire)
Nov-28-25 05:30PM	Forget CVS, Buy This Healthcare Stock Instead (Motley Fool)
11:30AM	Centene (CNC) Up 12.7% Since Last Earnings Report: Can It Continue? (Zacks)
08:50AM	UNH Battles MCR, Optum Bandages: But the Real Wild Card is Washington (Zacks)
Nov-26-25 11:00AM	Recent SNAP Disruptions Highlight Urgent Need for Sustained Action Against Food Insecurity (PR Newswire)

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Burdick Kenneth A	Director	Dec 03 '25	Sale	39.04	33,211	1,296,557	305,161	Dec 05 05:06 PM
Burdick Kenneth A	Director	Dec 04 '25	Sale	39.00	32,796	1,279,044	272,365	Dec 05 05:06 PM
Burdick Kenneth A	Director	Dec 04 '25	Proposed Sale	39.00	32,796	1,279,044		Dec 04 04:39 PM
Burdick Kenneth A	Director	Dec 03 '25	Proposed Sale	39.04	33,211	1,296,621		Dec 03 04:59 PM
Wayne S DeVeydt	Director	Oct 15 '25	Proposed Sale	35.84	5,489	196,737		Oct 15 03:29 PM
DeVeydt Wayne S	Director	Sep 09 '25	Proposed Sale	29.19	10,775	314,545		Sep 09 01:55 PM
LONDON SARAH	Chief Executive Officer	Aug 08 '25	Buy	25.50	19,230	490,365	845,275	Aug 11 05:28 PM
Samuels Theodore R. II	Director	Jul 28 '25	Buy	27.62	9,000	248,580	32,000	Jul 29 06:01 PM
FASOLA KENNETH J	Officer	Mar 21 '25	Proposed Sale	59.06	8,500	501,970		Mar 21 10:37 AM

BMY Bristol-Myers Squibb Co daily Stock Chart

Peers: PFE JNJ MRK LLY ABBV GILD AMGN AZN-D NVS

| Held by: VTI SCHD VOO IVV SPY VTV XLV JEPI VYM COWZ

Index	S&P 500	P/E	17.92	EPS (ttm)	3.46	Insider Own	0.18%	Shs Outstand	2.04B	Perf Week	12.61%
Market Cap	126.20B	Forward P/E	10.40	EPS next Y	5.96	Insider Trans	-1.51%	Shs Float	2.03B	Perf Month	9.29%
Enterprise Value	160.68B	PEG	-	EPS next Q	1.44	Inst Own	81.05%	Short Float	1.82%	Perf Quarter	33.40%
Income	7.05B	P/S	2.62	EPS this Y	-0.39%	Inst Trans	-1.27%	Short Ratio	2.54	Perf Half Y	36.66%
Sales	48.19B	P/B	6.80	EPS next Y	-2.68%	ROA	6.34%	Short Interest	36.98M	Perf YTD	14.92%
Book/sh	9.11	P/C	11.82	EPS next 5Y	-4.38%	ROE	33.84%	52W High	63.33 -2.12%	Perf Year	3.82%
Cash/sh	5.24	P/FCF	8.25	EPS past 3/5Y	5.48% -	ROIC	10.87%	52W Low	42.52 45.79%	Perf 3Y	-12.97%
Dividend Est.	2.52 (4.07%)	EV/EBITDA	8.47	Sales past 3/5Y	1.45% 2.54%	Gross Margin	73.74%	Volatility	2.90% 2.24%	Perf 5Y	-0.35%
Dividend TTM	2.49 (4.02%)	EV/Sales	3.33	EPS Y/Y TTM	178.35%	Oper. Margin	31.10%	ATR (14)	1.40	Perf 10Y	-0.27%
Dividend Ex-Date	Jan 02, 2026	Quick Ratio	1.17	Sales Y/Y TTM	-0.22%	Profit Margin	14.64%	RSI (14)	77.61	Recom	2.43
Dividend Gr. 3/5Y	4.37% 6.24%	Current Ratio	1.27	EPS Q/Q	-55.76%	SMA20	10.71%	Beta	0.27	Target Price	59.45
Payout	71.97%	Debt/Eq	2.43	Sales Q/Q	11.62%	SMA50	14.77%	Rel Volume	1.18	Prev Close	59.52
Employees	34100	LT Debt/Eq	2.31	Earnings	Feb 05 BMO	SMA200	27.68%	Avg Volume	14.53M	Price	61.99
IPO	Jul 05, 1929	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.77% 1.80%	Trades		Volume	17,114,167	Change	4.15%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Upgrade	UBS	Neutral → Buy	$65
Dec-15-25	Upgrade	BofA Securities	Neutral → Buy	$61
Dec-12-25	Upgrade	Guggenheim	Neutral → Buy	$62
Nov-13-25	Initiated	Scotiabank	Sector Perform	$45
Aug-05-25	Downgrade	Daiwa Securities	Outperform → Neutral	$42
Apr-22-25	Initiated	Piper Sandler	Overweight
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$55
Dec-16-24	Upgrade	Jefferies	Hold → Buy	$70
Dec-10-24	Resumed	BofA Securities	Neutral	$63
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-13-24	Upgrade	Daiwa Securities	Neutral → Outperform
Nov-12-24	Upgrade	Leerink Partners	Market Perform → Outperform	$73
Oct-25-24	Downgrade	Citigroup	Buy → Neutral	$75 → $55
Oct-17-24	Initiated	Bernstein	Mkt Perform	$56
Jul-29-24	Downgrade	Barclays	Overweight → Equal Weight	$41
Mar-11-24	Downgrade	Societe Generale	Buy → Hold
Feb-06-24	Downgrade	Redburn Atlantic	Buy → Neutral	$77 → $54
Jan-03-24	Downgrade	BofA Securities	Buy → Neutral	$68 → $60
Nov-15-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$68 → $55
Nov-09-23	Initiated	Deutsche Bank	Hold	$55

Show Previous Ratings

Feb-06-26 07:35AM	Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued Declines in the Portfolio. (Barrons.com)
06:48AM	BMS reports flat revenue growth for full-year 2025 (Pharmaceutical Technology)
04:27AM	Bristol Myers Squibb Q4 Earnings Call Highlights (MarketBeat)
12:34AM	BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus (StockStory)
Feb-05-26 04:31PM	Bristol Myers Expects Sales To Decline This Year; So Why Is The Stock Rising? (Investor's Business Daily)
02:46PM	Loading…
02:46PM	Analyst Report: Bristol-Myers Squibb Company (Morningstar Research)
02:04PM	Bristol-Myers Squibb Co (BMY) Q4 2025 Earnings Call Highlights: Strong Growth in New Products ... (GuruFocus.com)
01:29PM	Bristol Myers Earnings Reveal Struggling Legacy Drug Business. Why the Stock Is Rising. (Barrons.com)
11:08AM	Weekly Jobless Claims Exceed Expectations (Zacks)
10:50AM	Bristol Myers Just Crushed Earnings, and the Real Catalyst Hasnt Even Hit Yet (24/7 Wall St.)
10:49AM	Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates (Zacks)
10:32AM	Jobless Claims Pop Up a Bit, Major Morning for Earnings (Zacks)
10:25AM	Bristol Myers Stock Rises on Earnings. This Drug Portfolio Continues to Be a Drag. (Barrons.com)
10:07AM	Bristol Myers Flags Data-Rich 2026 After Solid Quarter (Benzinga)
09:57AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
09:30AM	Loading…
09:30AM	Bristol Myers (BMY) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
09:04AM	These Stocks Are Todays Movers: Alphabet, Strategy, Qualcomm, Broadcom, Estee Lauder, Bristol Myers, Amazon, and More (Barrons.com)
08:51AM	Bristol Myers Rises Inside A Buy Zone On Street-Beating 2026 Outlook (Investor's Business Daily)
08:14AM	Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025 (StockStory)
08:10AM	Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:17AM	Bristol Myers Stock Rises. Why Fourth-Quarter Earnings Are Exciting Investors. (Barrons.com)
07:09AM	Bristol Myers: Q4 Earnings Snapshot (Associated Press Finance)
07:09AM	Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth (The Wall Street Journal)
06:59AM	Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025 (Business Wire)
04:59AM	Amazon.com headlines earnings slate (MarketWatch)
04:18AM	Stock Market Today: Dow, S&P 500 and Nasdaq mixed as AI spending and disruption weigh on tech sector after Alphabet results; silver dives; bitcoin falls near 70k; Amazon.com earnings on tap. (MarketWatch)
Feb-04-26 07:00PM	Amazon earnings, Fed commentary, mortgage rates: What to Watch (Yahoo Finance Video)
01:40PM	What's Going On With Bristol-Myers Squibb Stock Today? (Benzinga)
07:05AM	GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
06:59AM	Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi (Business Wire)
10:10PM	Loading…
Feb-03-26 10:10PM	Bristol-Myers Squibb Earnings: What To Look For From BMY (StockStory)
11:39AM	Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results? (Zacks)
06:59AM	Bristol Myers Squibb Introduces 'Change the Target. Change Whats Possible. to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care (Business Wire)
05:12AM	Bristol-Myers Squibb (BMY) Poised for Upside With Registrational Data Ahead (Insider Monkey)
Feb-02-26 07:28PM	Bristol-Myers Squibb Company (BMY): A Bull Case Theory (Insider Monkey)
11:12AM	Market Awaits January Manufacturing Numbers (Zacks)
10:35AM	Six More Weeks of Q4 Earnings Season? (Zacks)
10:25AM	What's in Store for These 5 Pharma Bigwigs This Earnings Season? (Zacks)
10:00AM	iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
09:15AM	Unveiling Bristol Myers (BMY) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
Feb-01-26 01:27PM	Piper Sandler Raises Bristol Myers (BMY) PT to $66 Citing Pipeline Visibility (Insider Monkey)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 05:10PM	Citi Raises Bristol-Myers (BMY) Target as Sector Outlook Improves into 2026 (Insider Monkey)
08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:20AM	3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year (Motley Fool)
03:00AM	How Big Pharma is navigating a $300 billion patent cliff (Pharma Voice)
Jan-29-26 10:02PM	Piramal Pharma Ltd (BOM:543635) Q3 2026 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
10:00AM	Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for (Zacks)
02:07AM	Bristol Myers Squibb (BMY), Microsoft (MSFT) Partner to Enhance Early Lung Cancer Detection Through AI (Insider Monkey)
Jan-28-26 05:45PM	Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
10:49AM	The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears (Pharmaceutical Technology)
09:48AM	Some of Pharma's Biggest Brands Face a New Reality (GuruFocus.com)
05:51AM	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle (Benzinga)
05:21AM	Bristol-Myers Squibb Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Jan-27-26 06:09PM	Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy (Insider Monkey)
Jan-26-26 09:00AM	Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know (Zacks)
Jan-24-26 02:20PM	2 Under-the-Radar Biotech Stocks Set to Boom in 2026 (Motley Fool)
Jan-23-26 06:50PM	AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term. (Motley Fool)
01:05PM	Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? (Motley Fool)
07:18AM	JANX Enters Global Oncology Collaboration With BMY, Stock Rises (Zacks)
01:30AM	AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next. (Barrons.com)
Jan-22-26 02:02PM	Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million (Benzinga)
01:01PM	BMS bets on Januxs novel solid tumour therapy through $850m deal (Pharmaceutical Technology)
09:15AM	Is BMY's Deep Pipeline the Key to Its Next Growth Phase? (Zacks)
07:00AM	Bristol Myers buys into Januxs masked T cell engagers (BioPharma Dive)
Jan-21-26 09:47PM	Bristol-Myers (BMY): UBS Turns Bullish as Biotech and Pharma Show Signs of a Recovery (Insider Monkey)
12:05PM	The Best Stocks to Invest $1,000 in Right Now (Motley Fool)
07:24AM	Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences (Benzinga)
07:10AM	Leerink Bullish on Bristol-Myers Squibb Company (BMY) Amid Ample Pipeline Optionality in 2026 (Insider Monkey)
Jan-20-26 02:45PM	Bristol-Myers Squibb (BMY) Upgraded to Buy by UBS, Noting a Skewed Risk/Reward Ratio for the Stock (Insider Monkey)
01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
01:02PM	Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool (Benzinga)
08:58AM	Profit Alert: Netflix Goes All-Cash, Microsoft Cracks Healthcare AI, and How You Win (24/7 Wall St.)
08:11AM	Bristol Myers partners with Microsoft for AI-driven lung cancer detection (Reuters)
07:10AM	This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. (Barrons.com)
06:59AM	Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer (Business Wire)
04:57AM	Scotiabank Notes Bristol-Myers Squibb Company (BMY) as Appealing Investment in 2026 (Insider Monkey)
Jan-19-26 02:18PM	2 Dividend Stocks to Buy and Hold For 10 Years (Motley Fool)
09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
08:20AM	2 Buffett Stocks to Load Up On-And 1 to Ditch (MarketBeat)
Jan-16-26 05:45PM	Bristol Myers Squibb (BMY) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Jan-15-26 04:02AM	3 Former Stock Picks Where Technical Indicators Say Buy (Barrons.com)
Jan-14-26 12:53PM	Bristol-Myers Squibb Reports Positive Phase 3 SCOUT-HCM Results for Camzyos in Adolescent Patients (Insider Monkey)
12:06PM	Will Positive Data on Camzyos Strengthen BMY's Cardiovascular Portfolio? (Zacks)
09:35AM	Will Keytruda Continue to Aid Merck's Top Line in Q4 Earnings? (Zacks)
09:16AM	Bristol Myers price target raised to $60 from $54 at Leerink (TipRanks)
Jan-13-26 12:35PM	ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon (Zacks)
09:00AM	Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock (Zacks)
06:34AM	JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff (Pharmaceutical Technology)
Jan-12-26 01:39PM	Beam Therapeutics Stock Surges: What's Driving The Sudden Jump? (Benzinga)
01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
01:01PM	What $6,500 a Month Really Looks Like in Retirement at 67 (24/7 Wall St.)
11:38AM	'Biotech Super Bowl' Lands With a Thud. Stocks Slide on Lack of Deal News. (Barrons.com)
10:12AM	Scotiabank Raises Bristol-Myers (BMY) PT to $60 Citing Catalyst-Rich 2026 Growth (Insider Monkey)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
06:59AM	Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) (Business Wire)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
Jan-09-26 11:19AM	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (Reuters)

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Feb 01 '26	Option Exercise	0.00	2,543	0	22,261	Feb 03 04:40 PM
Hickey Benjamin	President, RayzeBio Org.	Feb 01 '26	Option Exercise	0.00	10,079	0	18,868	Feb 03 04:39 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Nov 01 '25	Option Exercise	0.00	2,964	0	2,964	Nov 04 05:18 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Nov 01 '25	Option Exercise	0.00	6,281	0	22,383	Nov 04 05:15 PM
Shanahan Karin	EVP, Chief Supply Chain & Ops	Nov 01 '25	Option Exercise	0.00	6,281	0	20,078	Nov 04 05:13 PM
Gallman Cari	EVP, General Counsel	Oct 02 '25	Option Exercise	0.00	4,558	0	13,398	Oct 06 05:22 PM
Elkins David V	EVP, Chief Financial Officer	Sep 02 '25	Sale	47.33	56,000	2,650,480	167,379	Sep 03 06:46 PM
Short Bartie Wendy	EVP, Corporate Affairs	Sep 01 '25	Option Exercise	0.00	1,235	0	6,301	Sep 03 06:42 PM
Elkins David V	Officer	Sep 02 '25	Proposed Sale	47.30	56,000	2,648,800		Sep 02 11:16 AM
Gallman Cari	EVP, General Counsel	Aug 01 '25	Option Exercise	0.00	1,061	0	9,383	Aug 05 06:01 PM
Short Bartie Wendy	EVP, Corporate Affairs	Aug 02 '25	Option Exercise	0.00	738	0	5,444	Aug 05 05:58 PM
Short Bartie Wendy	EVP, Corporate Affairs	Aug 02 '25	Sale	44.23	378	16,719	5,066	Aug 05 05:58 PM
Short Bartie Wendy	EVP, Corporate Affairs	Jun 03 '25	Option Exercise	0.00	8,040	0	8,040	Jun 04 05:37 PM
Hickey Benjamin	President, RayzeBio Org.	May 09 '25	Sale	38.01	97	3,702	0	May 13 07:03 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Apr 25 '25	Buy	47.58	4,250	202,215	83,513	Apr 29 06:14 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Apr 01 '25	Option Exercise	0.00	3,306	0	15,489	Apr 03 05:15 PM
Plenge Robert M	EVP, Chief Research Officer	Mar 10 '25	Option Exercise	0.00	11,255	0	20,148	Mar 12 09:39 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Mar 10 '25	Option Exercise	0.00	23,150	0	26,937	Mar 12 09:37 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Mar 10 '25	Option Exercise	0.00	20,423	0	22,339	Mar 12 09:35 PM
Lenkowsky Adam	EVP, Chief Commercial Officer	Mar 10 '25	Option Exercise	0.00	16,684	0	20,017	Mar 12 09:34 PM
Poole Ahn Amanda	EVP, Chief People Officer	Mar 10 '25	Option Exercise	0.00	7,164	0	8,546	Mar 12 09:32 PM
LEUNG SANDRA	EVP, General Counsel	Mar 10 '25	Option Exercise	0.00	48,718	0	386,496	Mar 12 09:32 PM
Hoch Lynelle	President, Cell Therapy Org.	Mar 10 '25	Option Exercise	0.00	7,446	0	7,920	Mar 12 09:31 PM
Holzer Phil M	SVP and Controller	Mar 10 '25	Option Exercise	0.00	7,140	0	17,870	Mar 12 09:31 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Mar 10 '25	Option Exercise	0.00	44,098	0	99,040	Mar 12 09:30 PM
Gallman Cari	EVP, Corporate Affairs	Mar 10 '25	Option Exercise	0.00	7,588	0	11,626	Mar 12 09:29 PM
Elkins David V	EVP, Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	69,517	0	252,608	Mar 12 09:28 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Mar 10 '25	Option Exercise	0.00	60,034	0	152,898	Mar 12 09:27 PM
Hickey Benjamin	President, RayzeBio Org.	Mar 01 '25	Option Exercise	0.00	3,286	0	10,419	Mar 04 05:44 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Feb 20 '25	Buy	55.05	2,000	110,096	104,626	Feb 21 07:09 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Feb 14 '25	Buy	54.84	1,823	100,000	63,932	Feb 19 07:19 PM

CNC

Centene Corp

BMY

Bristol-Myers Squibb Co

Upgrade your FINVIZ experience